Read about the latest insights in skin cancer care with a new whitepaper on advanced basal cell carcinoma and advanced cutaneous squamous cell carcinoma. View the complimentary resource today!
Increased awareness of the nuances of diagnosing and treating patients with skin of color can improve training and research and help inform management.
Increased awareness of the nuances of diagnosing and treating patients with skin of color can improve training and research and help inform management.
A multidisciplinary workgroup has released updated guidelines for the management of atopic dermatitis (AD) in adults using topical therapies in a study published in the Journal of the American Academy of Dermatology.
A multidisciplinary workgroup has released updated guidelines for the management of atopic dermatitis (AD) in adults using topical therapies in a study published in the Journal of the American Academy of Dermatology.
In this interview with The Dermatologist, Dr Steven Feldman discusses his upcoming session, “Better Care for Psoriasis Patients,” to be presented at Dermatology Week Fall 2023.
In this interview with The Dermatologist, Dr Steven Feldman discusses his upcoming session, “Better Care for Psoriasis Patients,” to be presented at Dermatology Week Fall 2023.
Bridget E. Shields, MD, delved into the fascinating connection between conditions like IBD and their impact on the skin in her Fall Dermatology Week 2023 session, “Skin Complications of Gastrointestinal Diseases.”
Bridget E. Shields, MD, delved into the fascinating connection between conditions like IBD and their impact on the skin in her Fall Dermatology Week 2023 session, “Skin Complications of Gastrointestinal Diseases.”
Test your knowledge on managing acute flares in atopic dermatitis. Learn about eczema action plans, proactive care models, and key patient education strategies to improve outcomes.
Test your knowledge on managing acute flares in atopic dermatitis. Learn about eczema action plans, proactive care models, and key patient education strategies to improve outcomes.
Explore how patients and providers can align on defining atopic dermatitis (AD) flares to improve communication, treatment decisions, and shared decision-making. Take this interactive quiz to test your knowledge and learn how patient-centered...
Explore how patients and providers can align on defining atopic dermatitis (AD) flares to improve communication, treatment decisions, and shared decision-making. Take this interactive quiz to test your knowledge and learn how patient-centered...
How well do you understand the patient perspective on atopic dermatitis flares? Take this quiz to explore key patient-described flare indicators, emotional and social impacts, and insights from NEA research.
How well do you understand the patient perspective on atopic dermatitis flares? Take this quiz to explore key patient-described flare indicators, emotional and social impacts, and insights from NEA research.
Test your knowledge of how patients with atopic dermatitis (AD) define and experience flares. This quiz highlights key indicators, patient-described attributes, and insights from the NEA’s research into AD flare triggers and symptoms.
Test your knowledge of how patients with atopic dermatitis (AD) define and experience flares. This quiz highlights key indicators, patient-described attributes, and insights from the NEA’s research into AD flare triggers and symptoms.
1. How do JAK inhibitors differ from traditional immunosuppressant treatments for atopic dermatitis?a) They work extracellularly, directly blocking cytokines.b) They target inflammation at the intracellular level and are more selective.c)...
1. How do JAK inhibitors differ from traditional immunosuppressant treatments for atopic dermatitis?a) They work extracellularly, directly blocking cytokines.b) They target inflammation at the intracellular level and are more selective.c)...